Believability of real-world evidence (RWE) for informed regulatory decisions

被引：0
|
作者：
Leclerc, Jacinthe [1 ]
Brodovicz, Kimberly G. [2 ]
Chang, Stephen [3 ]
Assimon, Magdalene M. [4 ]
Urushihara, Hisashi [5 ]
Girman, Cynthia J. [6 ]
机构：
[1] Univ Quebec Trois Rivieres, Trois Rivieres, PQ, Canada
[2] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany
[3] US FDA, Rockville, MD 20857 USA
[4] Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA
[5] Keio Univ, Tokyo, Japan
[6] CERobs Consulting LLC, Chapel Hill, NC USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2021年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [41] Should real-world evidence be incorporated into regulatory approvals?
    Spitzer, Ernest
    Cannon, Christopher P.
    Serruys, Patrick W.
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (12) : 1155 - 1159
  • [42] Examining the Use of Real-World Evidence in the Regulatory Process
    Beaulieu-Jones, Brett K.
    Finlayson, Samuel G.
    Yuan, William
    Altman, Russ B.
    Kohane, Isaac S.
    Prasad, Vinay
    Yu, Kun-Hsing
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (04) : 843 - 852
  • [43] Use of Real-World Evidence in Regulatory Decisions for Traditional Chinese Medicine: Current Status and Future Directions
    Li, Pei
    Wang, Su
    Chen, Yuwen
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2024, 58 (01) : 34 - 41
  • [44] Real-World Evidence for Regulatory Decisions: Concomitant Administration of Zoster Vaccine Live and Pneumococcal Polysaccharide Vaccine
    Bruxvoort, Katia
    Sy, Lina S.
    Luo, Yi
    Tseng, Hung Fu
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2018, 187 (09) : 1856 - 1862
  • [45] Use of Real-World Evidence in Regulatory Decisions for Traditional Chinese Medicine: Current Status and Future Directions
    Pei Li
    Su Wang
    Yuwen Chen
    Therapeutic Innovation & Regulatory Science, 2024, 58 : 34 - 41
  • [46] Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions
    Wang, Shirley, V
    Sreedhara, Sushama Kattinakere
    Schneeweiss, Sebastian
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [47] Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions
    Shirley V. Wang
    Sushama Kattinakere Sreedhara
    Sebastian Schneeweiss
    Nature Communications, 13
  • [48] USE OF REAL-WORLD EVIDENCE IN EUROPEAN MEDICINES AGENCY DECISIONS
    Watson, C.
    Jones, G.
    Shaw, C.
    VALUE IN HEALTH, 2022, 25 (12) : S8 - S8
  • [49] Is Canada Moving towards a More Agile Regulatory Approval and Reimbursement Process with a Shifting Role for Real-World Evidence (RWE) for Oncology Drugs?
    Lau, Catherine Y.
    Rawson, Nigel S. B.
    CURRENT ONCOLOGY, 2024, 31 (09) : 5599 - 5607
  • [50] Real-World Evidence in Regulatory Decision Making: Time for Evidence Integration
    Miksad, Rebecca A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (05) : 1153 - 1155
12345